| Financial Year |
March 31 2023 |
| Monetary Funds |
470,517,108.86 |
| Held-for-trading Financial Assets |
570,494,083.33 |
| Notes Receivable |
-- |
| Accounts Receivable |
141,232,777.32 |
| Advances to Suppliers |
2,448,381.49 |
| Other Receivables |
12,302,277.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
159,595,419.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
457,683,450.38 |
| Total Current Assets |
1,814,273,497.57 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
18,977,226.02 |
| Fixed Assetes |
140,691,658.67 |
| Under-construction Projects |
3,076,534.96 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
16,640,539.58 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,715,184.92 |
| Deferred Income Tax Assets |
14,400,437.84 |
| Other Non-Current Assets |
2,273,300.00 |
| Sub-Total of Non-Current Assets |
725,876,352.77 |
| Total Assets |
2,540,149,850.34 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
380,300.00 |
| Notes Payable |
2,361,871.20 |
| Accounts Payable |
349,534,316.87 |
| Accounts Received In Advance |
6,244,139.58 |
| Employee Compensation Payable |
36,666,262.77 |
| Taxes Payable |
35,827,291.66 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
34,778,600.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,515,549.71 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
492,160,500.47 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
24,040,619.23 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
564,759,879.82 |
| Total Liabilities |
1,056,920,380.29 |
| Paid-In Capital(Or Share Stock) |
185,391,680.00 |
| Capital Surplus |
296,808,965.79 |
| Surplus Reserve |
68,925,849.64 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
491,773,297.19 |
| Minority Stockholder's Interest |
433,288,565.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,049,940,904.37 |
| Owner's Equity（Stockholder's Equity） |
1,483,229,470.05 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,540,149,850.34 |
